Targeting EGFR signalling pathway in triple negative breast cancer

<p>Epidermal growth factor receptor (EGFR) is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic response...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir: Albukhari, A
Rannpháirtithe: Ahmed, A
Formáid: Tráchtas
Teanga:English
Foilsithe / Cruthaithe: 2014
Ábhair: